Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Xie M, Vuko M, Rodriguez-Canales J, Zimmermann J, Schick M, O'Brien C, Paz-Ares L, Goldman JW, Garassino MC, Gay CM, Heymach JV, Jiang H, Barrett JC, Stewart RA, Lai Z, Byers LA, Rudin CM, Shrestha Y.
Xie M, et al.
Mol Cancer. 2024 May 30;23(1):115. doi: 10.1186/s12943-024-02014-x.
Mol Cancer. 2024.
PMID: 38811992
Free PMC article.
Clinical Trial.